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SUMMARY
Noroviruses are, after rotaviruses, the second most common causative agents of acute
gastroenteritis in young children. We studied norovirus genotypes in faecal specimens collected
from Finnish children followed-up prospectively in rotavirus vaccine trials. Almost 5000 faecal
specimens collected from cases of acute gastroenteritis were examined using reverse
transcriptase–PCR. A total of 1172 cases (25% of all acute gastroenteritis) were associated with
noroviruses. Of these, 96% were genogroup GII. GII.4 was the most common genotype (46%)
throughout the study period but the proportion of this genotype varied in diﬀerent norovirus
epidemic seasons. Additional norovirus genotypes detected were: GII.7 (15%), GII.3 (14%),
GII.1 (9%), GII.b (7%), GII.2 (3%), and GI.3 (2%). GII.4 dominated during the following
years: 1998–1999 (75%), 2002–2003 (88%) and 2006–2007 (98%) while recombinant genotype
GII.b was dominant between 2003 and 2004 (83%). In conclusion, genotypes GII.4 and GIIb
have emerged as predominant norovirus genotypes in endemic gastroenteritis aﬀecting young
infants and children in Finland.
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INTRODUCTION
Noroviruses (NoVs) are not only the leading causa-
tive agents of outbreaks of acute viral gastroenteritis
worldwide in people of all ages, but also the second
most common viral aetiological agents of severe
childhood gastroenteritis after rotavirus [1, 2].
Patel and co-workers [1] estimated that in children
aged <5 years residing in resource-rich countries,
NoVs cause y900000 episodes of gastroenteritis
necessitating a clinic visit, compared with resource-
poor countries in which NoVs may cause more than
one million hospitalizations and up to 200000 deaths
each year.
A high incidence of NoVs (20%) in acute gastro-
enteritis (AGE) aﬀecting young children was orig-
inally reported from Finland when stool specimens
collected for rotavirus studies in connection with a
rotavirus vaccine eﬃcacy trial in 1993–1995 were also
examined for human caliciviruses [3]. While many of
the community-acquired NoV cases were mild, some
were severe, and NoVs also accounted for about 10%
of AGE cases seen in hospital [4]. In the present study,
we examined the incidence and genotypes of NoVs in
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during 1993–2007, a period when large numbers of
infants and young children participated in several
rotavirus vaccine trials in Finland.
Most NoVs infecting humans belong to geno-
groups GI and GII. GI genogroup is further
subdivided into at least eight genotypes and GII
genogroup into 17 genotypes [5]. Of the two main
genogroups, GII is much more common worldwide
[6, 7]. Genotype GII.4 NoVs have predominated since
the mid-1990s in the USA, Europe and Oceania,
causing 70–80% of all NoV outbreaks in communi-
ties, nursing homes, schools, hospitals and cruise
ships associated with contaminated food or water
[8, 9]. GII.4 has also commonly been detected in en-
demic infections of children worldwide [10–14]. Of the
other genotypes, recombinant strain GIIb especially
has also been frequently reported in paediatric NoV
infections [11–13, 15].
In the past, NoV genotyping was performed solely
on the RNA-dependent RNA polymerase (RdRp)
region of open reading frame (ORF) 1 of the single-
stranded, positive-sense NoV RNA genome [16].
Later studies showed better segregation of the diﬀer-
ent strains into their respective genotypes by phylo-
genetic analysis of nucleotide sequences within the
capsid region of ORF2 [17]. However, genotyping
based solely on the capsid sequence would miss the
naturally occurring recombinant NoVs which cluster
into two distinct groups of NoV strains when regions
RdRp and capsid are subjected to phylogenetic
analysis [18, 19]. In this study, we genotyped NoVs
according to polymerase region as well as to the
capsid region.
METHODS
Clinical specimens
In total, 4727 faecal specimens were collected from
AGE cases in children up to age 3 years participating
in seven rotavirus vaccine eﬃcacy trials in several
diﬀerent regions in Finland from 1993 to 2007
[3, 20–23]. The vaccine study protocols and consent
forms had been approved by the appropriate
ethics committees and patients or legal guardians
volunteered for the study after having given in-
formed consent. Stool specimens were collected
from children receiving either placebo or rotavirus
vaccine whenever an episode of AGE occurred. AGE
was typically deﬁned as o3 looser than normal
stools and/or vomiting within any day. Specimens
collected within 14 days of the ﬁrst sample from
the same patient were considered to be duplicate
samples and excluded from the analysis. The
numbers of stool specimens from each year and
the genotyping methods applied are described in de-
tail in Table 1. Stool specimens were stored at x20 xC
until tested.
RNA extraction
For viral RNA extraction 10% (w/v) stool suspen-
sions were made in phosphate-buﬀered saline (PBS).
Extractions were performed using the QIAamp
1
Viral RNA Mini kit (Qiagen, Germany) according to
the manufacturer’s instructions. In some cases
(Table 1), RNA was extracted by binding to silica
particles in the presence of guanidine thiocyanate as
described earlier by Boom et al. [24]. Aliquots of
Table 1. Study specimens analysed and the methods used for RNA extraction and NoV genotyping 1993–2007
Study years
No. of
samples
NoV-positive
specimen, N (%)
Boom’s
extraction
QIAamp
Viral RNA
extraction
Region A*
genotyping
Region C*
genotyping
2007 106 57 (54) x+ + + (53)#
2002–2004 254 27 (11) x+ + x
2001–2003 569 90 (16) x+ + x
2000–2002 485 146 (31) +x + + (140)
1998–2001 1510 438 (29) x+ + x
1997–1999 326 101 (31) x+ + x
1993–1995$ 1477 313 (21) ++ (279) + (294) x
Total 4727 1172 (25) 1962 3044 1153 193
x, Not tested; +, tested.
* See Methods section and Figure 1.
# If not all specimens were tested the number in parentheses indicates the number of specimens tested.
$ Results published in [4].
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transcriptase (RT)–PCR testing.
RNA polymerase (region A) RT–PCR
For the specimens collected between 1994 and 1995
the detection of NoVs was performed using primer
mixture sets including reverse primer NVp110 and
forward primers NI, NVp69 and Np36 (Fig. 1) [25].
These primers detect both genogroup I and II NoVs
as well as sapovirus, and amplify 397 bp, 151 bp and
116 bp long PCR products from the RNA-dependent
RNA polymerase (RdRp) region. RT–PCR reactions
were performed as described previously [3].
For the specimens collected between 1997 and 2007,
as well as for 279 samples from 1994 to 1995 (to con-
ﬁrm genotype ﬁndings done by the RT–PCR method
described above), RNA polymerase region A detec-
tion was performed by the RT–PCR method reported
by Jiang and co-workers [26], modiﬁed by Farkas
and colleagues [27]. The primer mixture p289H,
I/p290H,I,J,K was used with additional primers
p289IUB (reverse: 5k-GATTACTCCARGTGG-
GAYTCMAC-3k) and p290IUB (forward: 5k-TGA-
CRATKTMATCATCMCCRTA-3k) to improve
detection of all genotypes. The RT reaction was per-
formed at 42 xC for 60 min with 2.5 ml RNA added to
the RT mixture (total volume 50 ml) containing
22.9 ml sterile water, 1rGeneAmp PCR buﬀer (Ap-
plied Biosystems, USA), 1.5m M GeneAmp MgCl2
(Applied Biosystems), 400 mM dNTPs each, 16 ng/ml
p289H,I,IUB reverse primer mixture, 10 U RNasin
1
(Promega, USA) and 70 U M-MLV Reverse Tran-
scriptase RNase Hx enzyme (Promega). Fifty micro-
litres of PCR reaction mixture consisting of 26.6 ml
sterilewater,2UGoTaqDNApolymerase(Promega),
1rGoTaq Green buﬀer (Promega), 0.5m M MgCl2
(Promega), and a mixture of p290H,I,J,K,IUB
forward primers (24 ng/ml) was added to the RT re-
action. The 40-cycle PCR was run in a GeneAmp
PCR system 9700 or Thermal Cycler 2720 (Applied
Biosystems) with the following conditions: primary
denaturation at 94 xC for 3 min, denaturation at
94 xC for 30 s, annealing at 42 xC for 1 min 30 s, ex-
tension at 72 xC for 1 min and ﬁnal extension at 72 xC
for 10 min. The PCR amplicons were analysed by
agarose gel electrophoresis to conﬁrm the correct size
of the product. This RT–PCR method for the detec-
tion of RdRp of caliciviruses simultaneously detected
both NoVs and sapoviruses and ampliﬁed a 319-bp
amplicon for NoVs and a 331-bp amplicon for sapo-
viruses. Positive PCR products were stored at x20 xC
for sequencing.
Capsid (region C) RT–PCR
To conﬁrm the genotyping by region A, RT–PCR
typing targeted at region C (Fig. 1) from the begin-
ning of the capsid region in ORF2 of NoVs was
studied for 193 specimens collected between
2000–2002 and 2007 (Table 1). Five microlitres of
RNA was ﬁrst reverse-transcribed as described by
Pang et al. [28], except that the reaction contained 1r
ﬁrst-strand buﬀer (Invitrogen, USA) and the ﬁnal
concentration of dNTPs was 375 mM each.
Synthesized cDNA was stored at x20 xC unless used
immediately for PCR reaction. A 317-bp fragment
was ampliﬁed with primers JV21 (reverse), JV24
(forward) [29] and an additional forward primer
JV24mod (5k-GTGAATGAAGATGGCGTCGA-3k)
5358 5374 6950
ORF1
ORF2
ORF3 Region A
Region C
116 bp
151 bp
397 bp
319 bp
317 bp
NI/NVp110
NVp69/NVp110
NVp36/NVp110
p289/p290
JV21/JV24/JV24mod
Fig. 1. Schematic presentation of norovirus genomic regions A and C (grey) [17], and RT–PCR primers (NI/NVp69/NVp36/
NVp110, p289H,I,IUB/p290H,I,J,K,IUB and JV21/JV24/JV24mod, described in the Methods section) used for reverse
transcriptase (RT)–PCR and genotyping. Numbers on the bar refer to the nucleotide positions in Norwalk GI.1 virus genome
(GenBank accession no. M87661). RT–PCR amplicon sizes in base pairs are noted in the boxes.
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performed with 5 ml cDNA added to PCR mixture
(total volume 50 ml) consisting of 22.5 ml sterile water,
2.5 U GoTaq DNA polymerase (Promega), 1r
GoTaq Green buﬀer (Promega), 1 mM MgCl2
(Promega), 200 mM dNTP (Promega) and 4 ng/ml
mixture of each of the above primers. The PCR run
conditions were identical to those described above for
RNA polymerase RT–PCR except that annealing
temperature was 49 xC.
Sequencing
All the positive PCR products were excised from
the electrophoresis gel, puriﬁed with QIAquick
1
Gel Extraction kit (Qiagen) according to the manu-
facturer’s instructions and sequenced using the Big
Dye
1 Terminator v. 1.1 Cycle Sequencing kit
(Applied Biosystems). The primers used for sequen-
cing were identical to those used in the RT–PCRs.
Ethanol precipitation puriﬁed sequencing PCR pro-
ducts were analysed using an automated sequencer
ABI PRISM
TM 310 Genetic Analyser (Applied
Biosystems).
Sequence analysis and genotyping
Sequences obtained by the ABI PRISM 310 Genetic
Analyser were aligned, veriﬁed and edited with the
program Sequencher
TM 4.8 software (Gene Codes
Corp., USA). Virus conﬁrmation and genotyping was
done using the Food-borne Viruses in Europe net-
work (FBVE) NoV genotyping tool (http://www.
rivm.nl/bnwww) and NCBI Blast
1 programs (http://
www.ncbi.nlm.nih.gov/BLAST/, nucleotide blast).
In addition, RdRp region A and capsid region C
(Fig. 1) sequences of the recombinant strains were
re-analysed with the new NoV genotyping tool of
FBVE (http://www.rivm.nl; National Institute
of Public Health and the Environment, The
Netherlands) to conﬁrm the genotyping.
RESULTS
A total of 4727 faecal specimens from AGE cases
were studied and 1172 (25%) cases were found to be
associated with NoVs, as determined by genotyping
according to region A sequences (Table 1). NoV
genotypes during the period 1994–2007 by month are
shown in Figure 2. The study period covered ten
seasons with each season starting in July and ending
in June. Of the 1149 genotyped NoV strains, 96%
were genogroup GII. GII.4 was the most common
genotype throughout the study period (46%), but it
appeared in varying proportions in the NoV epidemic
seasons (Fig. 2, Table 2). GII.4 was already present in
community-acquired cases in 1993–1994 with a 40%
share, but dominated in the seasons 1998–1999,
2002–2003 and 2006–2007 (Table 2, values in bold
face).
Additional NoV genotypes detected are listed in
Table 2. Other genotypes included: GI.6, GI.4, GII.9,
GI.2, GIIU, GIId which accounted for <1% each
(Fig. 2, Table 2). During the seasons 1999–2000 and
2003–2004, which followed the GII.4 peak seasons,
the shares of GII.4 were low (13% and 17%, re-
spectively), and genotypes GII.1, GII.7 and GII.b
dominated. In the early study years GII.4 was circu-
lating with GII.3 (1994–1998) and with GII.7
(1994–2002), followed by GII.1 (1999–2000) and
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Fig. 2. Norovirus (NoV) seasonality and genotype distribution in Finnish children aged <3 years throughout the study
period 1993–2007. From July 1995 to September 1997 and from June 2004 to January 2007 no specimens were collected.
Norovirus genotypes in Finnish children 271GII.b in the later seasons (2000–2007). Overall, of the
total ten study seasons GII.4 predominated in seven
seasons, while other genotypes predominated only in
one season each (Fig. 2, Table 2).
The second most common genotype throughout the
14 study years was GII.7, which appeared in multiple
seasons but never dominated (Fig. 2, Table 2).
Genotype GII.3 circulated largely in 1994–1995
(40–50%) and 1997–1998 (17%) but was not detected
after 2001. Genotype GII.1 was detected only rarely
in other seasons, but predominated in 2000. The ﬁrst
recombinant GII.b strains (GII.b–GII.2) appeared in
March 2000. GII.b reached a high prevalence in
2001–2002 and was the dominating genotype in 2004.
The most common GI strain GI.3 occurred during
1998–2003 with very low prevalence of 1–4%. Only a
few AGE cases with other GI strains (GI.6, GI.4,
GI.2) were occasionally detected (data not shown). In
1994–2002 there were more than eight diﬀerent
genotypes circulating among the study children, but
later, in 2002–2007, the number of diﬀerent genotypes
was at maximum three per season (Table 2).
To conﬁrm whether genotyping by capsid region C
would identify identical genotypes as determined by
polymerase region A, some of the specimens (years
2000–2002 and 2007, n=193) were genotyped for
both of these regions (Fig. 1, Table 1). Identical geno-
typing results were obtained for both regions in all
cases, except for the recombinant strains. Altogether
53 recombinant strains were found in 193 double
genotyped NoVs in 2001–2002. No recombinant
strains were found in 2007, when GII.4 was detected
almost exclusively (Tables 1 and 3). RNA polymerase
genotype GII.b occurred most commonly with capsid
genotype GII.3 (41 cases, 77%) and rarely with GII.1
(three cases, 6%). Polymerase type GII.7 occurred
with capsid genotype GII.6 (six cases, 11%) and
GII.14 (one case, 2%) (Table 3).
DISCUSSION
Rotavirus vaccination studies conducted in Finland
with follow-up AGE specimens oﬀered a unique op-
portunity to study extensively the prevalence of NoVs
in community-acquired AGE in infants and young
children. Due to genetic variation in NoVs, primer
selection for RT–PCR assays has been challenging.
Table 2. Most commonly found NoV genotypes in sporadic cases of acute gastroenteritis in Finnish children
1993–2007. From July 1995 to September 1997 and from June 2004 to January 2007 there were no specimens
available
Season* … 93–94 94–95 97–98 98–99 99–00 00–01 01–02 02–03 03–04 06–07
Genotype Percent of cases per season Total (%)
GII.4 40 40 47 76 13 38 37 88 17 98 46
GII.7 20 5 22 15 29 27 12 6 15
GII.3 40 51 17 2 3 1 14
GII.1 4 48 3 1 2 9
GII.b 2 12 28 4 83 7
GII.2 5 1 8 12 3
GI.3 2 4 2 3 2 2
Other# 59 2 3 9 7 4
N$ 15 279 58 196 197 125 153 51 18 57 1149
Bold values indicate peak years of GII.4 incidence.
* Season is a time period from July to June.
# Other genotypes detected (GI.6, GI.4, GII.9, GI.2, GIIU, GIId and undetermined).
$ Total number of NoV-positive specimens (in italics).
Table 3. Polymerase (region A) and capsid (region C)
genotype combinations of recombinant strains detected
in Finnish children in 2001–2002
Region A Region C No. of cases (%)
GII.b GII.3 41 (77)
GII.b GII.1 3 (6)
GII.b — 2 (4)
GII.7 GII.6 6 (11)
GII.7 GII.14 1 (2)
—, Undetermined.
272 L. Puustinen and othersIt is possible that in early study seasons from 1993 to
1995 NoV-positive specimens were missed when we
used polymerase region primers including NVp110
[25] which were shown to fail to detect some NoV
strains [30]. However, the large number of samples
allowed us to draw certain conclusions. The present
study showed that in children aged <3 years, NoVs
were responsible for about one quarter of AGE cases
in the community.
Overall, GII.4 was the most prevalent genotype in
young children during the study period 1994–2007,
followed by GII.7, GII.3, GII.1 and GII.b. In
European outbreaks of AGE in all ages 2001–2006
the most common genotypes were GII.4, GII.7, GII.2
and GII.b [8]. In European outbreaks GII.7 peaked in
2005–2006 [8] and in Finnish outbreaks in 2001 and
2002 [31]. However, in children we had already found
GII.7 in earlier seasons (1997–1998 and 1999–2001).
Consistent with the observations from outbreaks
in Finland and other European countries [8, 11, 31]
in winter 2001, GII.b was the third most common
genotype, and its relative role increased until winter
2004, when it was the predominant type (83%).
In contrast to our observation, in a Canadian study
[32] no correlation was found between the NoV
strains in the outbreaks and in sporadic childhood
AGE, but the follow-up period was only a little over
1 year.
In our study, genogroup GI strains were uncom-
mon and, therefore, appeared to be less common in
sporadic cases in children than in outbreaks. In
Finnish outbreaks in 1998–2002 GI strains were de-
tected in 13%, but we detected GI in <6% [31]. On
the other hand, both in the outbreaks and in our
study, GI.3 was the most common GI genotype [31].
In general, GI strains occur throughout the year
rather than seasonally, more often in water-mediated
rather than person-to-person-mediated outbreaks,
and only rarely in sporadic cases of NoV infections
[9, 33–35].
The total proportion of GII.4 NoV in young chil-
dren was 46% for the years 1994–2007 and 52% for
2001–2007. Genotype GII.4 has also been detected as
the predominant NoV genotype in paediatric sporadic
AGE cases reported elsewhere [11, 13, 14, 36]. The
peaks of genotype GII.4 in winters 2002–2003 and
2006–2007 detected in Finland, occurred at the same
time as peaks of GII.4 outbreaks elsewhere in Europe
and the USA [8, 9]. In 1998–1999 GII.4 was also seen
in Finnish outbreaks and this winter was also re-
ported as a GII.4 outbreak peak year in Germany
[31, 37]. Furthermore, from 2006 to 2008 GII.4 was
found in almost 90% of children hospitalized for
NoV AGE (Ra ¨ sa ¨ nen et al., unpublished obser-
vations). An increase in NoV activity in outbreaks
was seen in Finland and many other European coun-
tries in 2002 due to the emergence of a new GII.4
variant 2002 [8, 31, 37]. GII.4 variants 2006a and
2006b were responsible for large NoV outbreaks in
Finland in winter 2007 [38]. Analyses of genetic var-
iants of GII.4 in Finnish children for the peak years
are ongoing and will determine which subtypes were
responsible for these peaks.
Naturally occurring recombination events are
common in NoVs and the most common recombi-
nation site is the ORF1–ORF2 junction localized
upstream of the capsid gene [18, 19]. We found 77%
of the recombinants in our study consisted of a
combination of GII.b–GII.3, which was also the
most common recombinant strain elsewhere and
emerged recently as a causative agent for many out-
breaks in Europe, Australia, and Asia [15, 19, 33].
Genotype GII.b was the most common genotype in
Finnish outbreaks in 2001 but was not detected
in Finland before January 2001 [34] nor elsewhere in
Europe before August 2000 [35, 39]. In the present
study six GII.b cases had already been detected in
March–April 2000. This raised a new possibility
regarding the origin and transmission of the re-
combinant GII.b strains, which were previously
suspected to be in contaminated shellﬁsh in August
2000 [39]. Children with sporadic gastroenteritis
could serve as a reservoir for emerging epidemic
NoV strains as some NoV strains appeared in chil-
dren prior to emerging as epidemic outbreak strains
[13, 36]. To the best of our knowledge, we report
for the ﬁrst time the recombination of GII-7
polymerase with GII.14 capsid. However, the re-
combinant cases we described should be veriﬁed by
sequencing over the ORF1–ORF2 junction region to
exclude the possibility of mixed infections of diﬀer-
ent genotypes.
In conclusion, similar to ﬁndings worldwide,
GII.4 was found to be the predominant NoV geno-
type in endemic gastroenteritis in infants and young
children in Finland, at least since 1994. Recombinant
genotype GII.b was detected with increasing inci-
dence from March 2000 onwards. The shifts in NoV
genotypes may be associated with an increase in the
clinical signiﬁcance of NoV AGE in young children
overall, and warrant more in-depth studies on GII.4
variants.
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